| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |